US revokes emergency use of malaria drugs versus coronavirus

Doctor with stethoscope
Valley News - Health
Matthew Perrone, The Associated Press U.S. regulators revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause serious side effects Monday, June 15. The Food and Drug Administration said the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the FDA said the drugs’ unproven benefits “do not outweigh the known and potential risks.” The decades-old drugs, also prescribed for lupus and rheumatoid arthritis, can cause heart rhythm problems, severely low blood pressure and muscle or nerve damage. The move means that shipments of the drugs obtained by the federal government will no longe
Subscribe or log in to read the rest of this content.